Navigation Links
Advanced Clinical Joins MedNet Solutions' iMedNet Partner Program
Date:10/25/2012

MINNETONKA, Minn., Oct. 25, 2012 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Advanced Clinical, a leading provider of clinical research services, are pleased to announce that Advanced Clinical has joined the iMedNet Partner Program and will offer iMedNet EDC as an eClinical solution to support the research initiatives of their pharmaceutical, biotechnology, and medical device customers. With iMedNet EDC, Advanced Clinical now has a ground-breaking, cloud-based eClinical platform to quickly, easily and affordably build their customers' studies.

"We are excited to partner with MedNet Solutions and offer the iMedNet platform to our clients," stated Leo Sheridan, President and CEO of Advanced Clinical.  "The iMedNet technology provides clients both the functionality and flexibility they need in an EDC solution."

"MedNet is honored to welcome Advanced Clinical – a highly experienced and well respected CRO serving a broad range of therapeutic areas – into our iMedNet Partner Program," remarked Brian Sweeney, Vice President of Business Development at MedNet Solutions.  "iMedNet will provide an ideal infrastructure to support their 'collaborative and innovative' approach to each client engagement."

Please contact MedNet Solutions for additional information on iMedNet EDC or the iMedNet Partner Program, and Advanced Clinical for more details on their complete lineup of CRO services for the life sciences community.

About MedNet Solutions
MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market.  MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes.  Since 2000, MedNet has successfully supported pharmaceutical, medical device, biotechnology, and contract research organizations (CROs) on clinical research conducted around the world.  These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success.  For more information, please visit www.mednetstudy.com.

About Advanced Clinical
Advanced Clinical provides full-service CRO and strategic resourcing solutions for the life sciences industry.  With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for pharmaceutical, biopharmaceutical, biotechnology, and medical device organizations.  Advanced utilizes a value-based, "One Team" approach.  To learn more, visit www.advancedclinical.com.

Contact Information:

Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
USA
(763) 258-2735

Kristin Kelley
Associate Director, Marketing
Advanced Clinical
10 Parkway North, Suite 350
Deerfield, IL  60015
USA
(847) 418-3724


'/>"/>
SOURCE MedNet Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
2. New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
3. MARC travel awards announced for the AAI 2012 Advanced Course in Immunology
4. Advanced Photon Source and Canadian Light Source strengthen ties
5. Adoption of advanced techniques could propel crop improvement
6. Advanced Membrane Technology V Conference
7. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
8. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
9. New clinical trial explores novel noninvasive colon cancer screening test
10. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
11. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical ... 12.14 billion by 2021 from USD 5.31 billion in 2016, at ... ... mainly driven by technological advancements in medical devices, launch of a ... preference for wireless connectivity among healthcare providers, and increasing focus on ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/15/2016)... Advancements in biometrics will radically ... wellbeing (HWW), and security of vehicles by ... vehicles begin to feature fingerprint recognition, iris ... monitoring, brain wave monitoring, stress detection, fatigue ... detection. These will be driven by built-in, ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... Geneva, Switerland (PRWEB) , ... January 24, 2017 ... ... the first commercially available malaria Plasmodium falciparum culture panels with standard concentrations of ... panels, which are available in a range of concentrations from six different malaria ...
(Date:1/24/2017)... ... January 23, 2017 , ... Edward ... first-ever recipient of the National Academy of Sciences Prize in Food and Agriculture ... nutrition. , The annual National Academy of Sciences (NAS) Prize in Food and ...
(Date:1/24/2017)... 2017   Instrument Business Outlook ( ... MN ) the 2016 Company of the ... newsletter tracking developments in the analytical and life ... consistently achieved outstanding technical, operational and financial results ... of IBO. "In 2016, Bio-Techne capitalized on opportunities ...
(Date:1/23/2017)... -- Spherix Incorporated (Nasdaq: SPEX ) an intellectual ... and monetization of intellectual property, today provided an update ... Anthony Hayes , Chief Executive Officer of Spherix, stated, ... with shareholders about the status of existing monetization efforts ... patent assets that fit with our current holdings.  We ...
Breaking Biology Technology: